These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


265 related items for PubMed ID: 30659925

  • 1. Glaucocalyxin A-induced oxidative stress inhibits the activation of STAT3 signaling pathway and suppresses osteosarcoma progression in vitro and in vivo.
    Mao M, Zhang T, Wang Z, Wang H, Xu J, Yin F, Wang G, Sun M, Wang Z, Hua Y, Cai Z.
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun 01; 1865(6):1214-1225. PubMed ID: 30659925
    [Abstract] [Full Text] [Related]

  • 2. Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the JAK2/STAT3 Signaling Pathway.
    Jia F, Liu Y, Dou X, Du C, Mao T, Liu X.
    Oxid Med Cell Longev; 2022 Jun 01; 2022():8245614. PubMed ID: 35116094
    [Abstract] [Full Text] [Related]

  • 3. Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways.
    Zuo D, Zhou Z, Wang H, Zhang T, Zang J, Yin F, Sun W, Chen J, Duan L, Xu J, Wang Z, Wang C, Lin B, Fu Z, Liao Y, Li S, Sun M, Hua Y, Zheng L, Cai Z.
    J Cell Mol Med; 2017 Feb 01; 21(2):208-221. PubMed ID: 27624867
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. CYT997(Lexibulin) induces apoptosis and autophagy through the activation of mutually reinforced ER stress and ROS in osteosarcoma.
    Wang Z, Yin F, Xu J, Zhang T, Wang G, Mao M, Wang Z, Sun W, Han J, Yang M, Jiang Y, Hua Y, Cai Z.
    J Exp Clin Cancer Res; 2019 Jan 31; 38(1):44. PubMed ID: 30704503
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway.
    Park KR, Yun HM, Quang TH, Oh H, Lee DS, Auh QS, Kim EC.
    Oncotarget; 2016 Feb 09; 7(6):6960-71. PubMed ID: 26755649
    [Abstract] [Full Text] [Related]

  • 9. Glaucocalyxin A exerts anticancer effect on osteosarcoma by inhibiting GLI1 nuclear translocation via regulating PI3K/Akt pathway.
    Zhu J, Sun Y, Lu Y, Jiang X, Ma B, Yu L, Zhang J, Dong X, Zhang Q.
    Cell Death Dis; 2018 Jun 13; 9(6):708. PubMed ID: 29899333
    [Abstract] [Full Text] [Related]

  • 10. Chloroquine suppresses proliferation and invasion and induces apoptosis of osteosarcoma cells associated with inhibition of phosphorylation of STAT3.
    Chen C, Zhang H, Yu Y, Huang Q, Wang W, Niu J, Lou J, Ren T, Huang Y, Guo W.
    Aging (Albany NY); 2021 Jun 24; 13(13):17901-17913. PubMed ID: 34170850
    [Abstract] [Full Text] [Related]

  • 11. Catalpol suppresses osteosarcoma cell proliferation through blocking epithelial-mesenchymal transition (EMT) and inducing apoptosis.
    Wang L, Xue GB.
    Biochem Biophys Res Commun; 2018 Jan 01; 495(1):27-34. PubMed ID: 29032182
    [Abstract] [Full Text] [Related]

  • 12. Bruceantinol targeting STAT3 exerts promising antitumor effects in in vitro and in vivo osteosarcoma models.
    Miao J, Chen S, Cao H, Ding Z, Li Y, Wang W, Nundlall K, Deng Y, Li J.
    Mol Carcinog; 2024 Jun 01; 63(6):1133-1145. PubMed ID: 38426797
    [Abstract] [Full Text] [Related]

  • 13. Role of crosstalk between STAT3 and mTOR signaling in driving sensitivity to chemotherapy in osteosarcoma cell lines.
    Wang YT, Tang F, Hu X, Zheng CX, Gong TJ, Zhou Y, Luo Y, Min L.
    IUBMB Life; 2020 Oct 01; 72(10):2146-2153. PubMed ID: 33448097
    [Abstract] [Full Text] [Related]

  • 14. Glaucocalyxin A impairs tumor growth via amplification of the ATF4/CHOP/CHAC1 cascade in human oral squamous cell carcinoma.
    Wang X, He MJ, Chen XJ, Bai YT, Zhou G.
    J Ethnopharmacol; 2022 May 23; 290():115100. PubMed ID: 35151835
    [Abstract] [Full Text] [Related]

  • 15. Dynasore suppresses cell proliferation, migration, and invasion and enhances the antitumor capacity of cisplatin via STAT3 pathway in osteosarcoma.
    Zhong B, Shi D, Wu F, Wang S, Hu H, Cheng C, Qing X, Huang X, Luo X, Zhang Z, Shao Z.
    Cell Death Dis; 2019 Sep 18; 10(10):687. PubMed ID: 31534119
    [Abstract] [Full Text] [Related]

  • 16. Stattic sensitizes osteosarcoma cells to epidermal growth factor receptor inhibitors via blocking the interleukin 6-induced STAT3 pathway.
    Wang S, Wang Y, Huang Z, Wei H, Wang X, Shen R, Lan W, Zhong G, Lin J.
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec 08; 53(12):1670-1680. PubMed ID: 34693451
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of Raddeanin A is mediated by Jun amino-terminal kinase activation and signal transducer and activator of transcription 3 inhibition in human osteosarcoma.
    Wang Z, Shen J, Sun W, Zhang T, Zuo D, Wang H, Wang G, Xu J, Yin F, Mao M, Zhou Z, Hua Y, Cai Z.
    Cancer Sci; 2019 May 08; 110(5):1746-1759. PubMed ID: 30907478
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of the JAK2/STAT3 signaling pathway exerts a therapeutic effect on osteosarcoma.
    Yan J, Wang Q, Zou K, Wang L, Schwartz EB, Fuchs JR, Zheng Z, Wu J.
    Mol Med Rep; 2015 Jul 08; 12(1):498-502. PubMed ID: 25760445
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of STAT3 blocks protein synthesis and tumor metastasis in osteosarcoma cells.
    Zuo D, Shogren KL, Zang J, Jewison DE, Waletzki BE, Miller AL, Okuno SH, Cai Z, Yaszemski MJ, Maran A.
    J Exp Clin Cancer Res; 2018 Oct 04; 37(1):244. PubMed ID: 30286779
    [Abstract] [Full Text] [Related]

  • 20. Water extract of sporoderm-broken spores of Ganoderma lucidum enhanced pd-l1 antibody efficiency through downregulation and relieved complications of pd-l1 monoclonal antibody.
    He J, Zhang W, Di T, Meng J, Qi Y, Li G, Zhang Y, Su H, Yan W.
    Biomed Pharmacother; 2020 Nov 04; 131():110541. PubMed ID: 33152901
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.